Tatva Chintan Pharma Chem (BOM:543321) Debt-to-Equity : 0.02 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem Debt-to-Equity?

Tatva Chintan Pharma Chem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹136 Mil. Tatva Chintan Pharma Chem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹6 Mil. Tatva Chintan Pharma Chem's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹7,371 Mil. Tatva Chintan Pharma Chem's debt to equity for the quarter that ended in Mar. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tatva Chintan Pharma Chem's Debt-to-Equity or its related term are showing as below:

BOM:543321' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.44 Max: 0.97
Current: 0.02

During the past 6 years, the highest Debt-to-Equity Ratio of Tatva Chintan Pharma Chem was 0.97. The lowest was 0.02. And the median was 0.44.

BOM:543321's Debt-to-Equity is ranked better than
96.05% of 1392 companies
in the Chemicals industry
Industry Median: 0.35 vs BOM:543321: 0.02

Tatva Chintan Pharma Chem Debt-to-Equity Historical Data

The historical data trend for Tatva Chintan Pharma Chem's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem Debt-to-Equity Chart

Tatva Chintan Pharma Chem Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.77

0.54

0.25

0.33

0.02

Tatva Chintan Pharma Chem Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial												0.33	N/A	0.08	N/A	0.02

Competitive Comparison of Tatva Chintan Pharma Chem's Debt-to-Equity

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tatva Chintan Pharma Chem's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's Debt-to-Equity falls into.

Tatva Chintan Pharma Chem Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tatva Chintan Pharma Chem's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(136.32	+	6.39)	/	7370.82
	=	0.02

Tatva Chintan Pharma Chem's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(136.32	+	6.39)	/	7370.82
	=	0.02

Tatva Chintan Pharma Chem (BOM:543321) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tatva Chintan Pharma Chem Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tatva Chintan Pharma Chem (BOM:543321) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

TATVA:India

Address

Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010

Website

https://www.tatvachintan.com

Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines